Back

Short dual antiplatelet strategy following left atrial appendage closure with Watchman and Watchman FLX: 1-year outcomes

23 April 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Stroke prevention with and without LAAO Left Atrial Appendage Closure EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Andre Briosa E Gala

Bern University Hospital, Inselspital, Bern (Switzerland)

7 More presentations in this session

Presentation thumbnail
Left atrial appendage closure in the presence of thrombus: incidence, technique and outcomes
Doctor A. Fontenla Cerezuela (Pozuelo de Alarcon, Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Periprocedural safety and efficacy after left atrial appendage closure in a large UK tertiary centre: 10-year experience
Doctor A. Briosa E Gala (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Is transesophageal echocardiogram mandatory for patients undergoing ablation for right atrial flutter with uninterrupted anticoagulants? A prospective single registry.
Doctor A. Suzat (Saint Priest En Jarez, FR)
Abstract Slides Video
Presentation thumbnail
Mitral regurgitation attenuates thrombotic risk in nonrheumatic atrial fibrillation: a new CHA2DS2-VASc score risk modifier?
Doctor S. Van Laer (Edegem, BE)
Abstract Slides Video
Presentation thumbnail
Socioeconomic trends in oral anticoagulation therapy for atrial fibrillation patients with low risk of stroke
Doctor E. Danielsen Lunde (Aalborg, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Stroke prevention with and without LAAO

The Event

Event poster

EHRA 2021

23 April - 25 April 2021
You may be interested in
thumbnail
Congress Presentation
Left atrial appendage closure in atrial fibrillation: gaps in knowledge
thumbnail
Congress Presentation
Pros and cons of endocardial left atrial appendage closure
thumbnail
Congress Session
Stroke prevention in atrial fibrillation: do not forget the left atrial appendage!

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources